Monthly Prescribing Reference11h
Tevimbra With Chemo Approved for Gastric/Gastroesophageal Junction Cancers
The approval was based on data from the randomized, placebo-controlled, double-blind, phase 3 RATIONALE-305 trial.
Monthly Prescribing Reference11h
FDA Approval Increases Eligibility for Cystic Fibrosis Medication Trikafta
According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.
Monthly Prescribing Reference10h
Atogepant Superior for Efficacy, Functional Measures in Migraine
(HealthDay News) — For adults with migraine, atogepant 60mg once daily was superior to placebo for efficacy and functional measures of treatment across 3 trials, according to research published online ...